Andrew Spaventa - 15 Dec 2023 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Dec 2023
Net transactions value
$0
Form type
4
Filing time
18 Dec 2023, 17:39:35 UTC
Previous filing
20 Nov 2023
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +14,583 +149% 24,349 15 Dec 2023 Direct F1
transaction OMIC Common Stock Gift $0 -14,583 -60% $0.000000 9,766 15 Dec 2023 Direct F2
transaction OMIC Common Stock Gift $0 +14,583 +0.36% $0.000000 4,075,789 15 Dec 2023 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -14,583 -7.1% 189,583 15 Dec 2023 Common Stock 14,583 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.